Offer - Urjas Oil for just ₹ 1 X
Emletra Tablet (60) is a prescription medicine that is available as a Tablet. The alternative uses of Emletra Tablet (60) have also been explained below.
The right dosage of Emletra Tablet (60) depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Emletra Tablet (60) are Headache. Besides the aforementioned side effects, there are other adverse effects of Emletra Tablet (60) as well, which are listed below. Normally, these side effects of Emletra Tablet (60) are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Emletra Tablet (60)'s effect during pregnancy is Moderate and Moderate while nursing. Further, the section on Emletra Tablet (60) related warnings talks about Emletra Tablet (60)'s effects on the liver, heart and kidney.
Emletra Tablet (60) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Emletra Tablet (60) in conditions like Liver Disease, Hemophilia. Other contraindications of Emletra Tablet (60) have been discussed in the sections ahead.
Besides this, Emletra Tablet (60) may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Emletra Tablet (60) is not safe while driving, and is is not addictive in nature.
Emletra Tablet (60) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Emletra Tablet (60) safe for pregnant women?
Emletra can have harmful effects in pregnant women. If you experience any discomfort after using Emletra, then discontinue the use and take your doctor's advice.
Is the use of Emletra Tablet (60) safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Emletra. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Emletra Tablet (60) on the Kidneys?
Using Emletra does not have any harmful effects on kidneys.
What is the effect of Emletra Tablet (60) on the Liver?
Emletra may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Emletra Tablet (60) on the Heart?
Very few cases of side effects of Emletra on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Emletra Tablet (60) unless your doctor advises you to do so -
Is this Emletra Tablet (60) habit forming or addictive?
Emletra Tablet (60) is not addictive in nature.
Interaction between Food and Emletra Tablet (60)
Taking Emletra Tablet (60) with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Emletra Tablet (60)
Consumption of alcohol and Emletra Tablet (60) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvir (ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 810
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 939-941
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Kaletra (lopinavir and ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 811